HRP920491B1 - O-methyl derivatives of azithromycin a, process and intermediates for their preparation, and process of preparation and use thereof in the preparation of pharmaceuticals - Google Patents

O-methyl derivatives of azithromycin a, process and intermediates for their preparation, and process of preparation and use thereof in the preparation of pharmaceuticals

Info

Publication number
HRP920491B1
HRP920491B1 HRP-1409/90A HRP920491A HRP920491B1 HR P920491 B1 HRP920491 B1 HR P920491B1 HR P920491 A HRP920491 A HR P920491A HR P920491 B1 HRP920491 B1 HR P920491B1
Authority
HR
Croatia
Prior art keywords
preparation
azithromycin
pharmaceuticals
intermediates
methyl derivatives
Prior art date
Application number
HRP-1409/90A
Other languages
English (en)
Inventor
Slobodan Dokic
Original Assignee
Slobodan Dokic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slobodan Dokic filed Critical Slobodan Dokic
Priority to HRP-1409/90A priority Critical patent/HRP920491B1/xx
Publication of HRP920491A2 publication Critical patent/HRP920491A2/hr
Publication of HRP920491B1 publication Critical patent/HRP920491B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HRP-1409/90A 1990-07-18 1992-09-25 O-methyl derivatives of azithromycin a, process and intermediates for their preparation, and process of preparation and use thereof in the preparation of pharmaceuticals HRP920491B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP-1409/90A HRP920491B1 (en) 1990-07-18 1992-09-25 O-methyl derivatives of azithromycin a, process and intermediates for their preparation, and process of preparation and use thereof in the preparation of pharmaceuticals

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
YU140990 1990-07-18
HRP-1409/90A HRP920491B1 (en) 1990-07-18 1992-09-25 O-methyl derivatives of azithromycin a, process and intermediates for their preparation, and process of preparation and use thereof in the preparation of pharmaceuticals

Publications (2)

Publication Number Publication Date
HRP920491A2 HRP920491A2 (en) 1994-08-31
HRP920491B1 true HRP920491B1 (en) 1998-10-31

Family

ID=25554060

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP-1409/90A HRP920491B1 (en) 1990-07-18 1992-09-25 O-methyl derivatives of azithromycin a, process and intermediates for their preparation, and process of preparation and use thereof in the preparation of pharmaceuticals

Country Status (20)

Country Link
US (1) US5250518A (de)
EP (1) EP0467331B1 (de)
JP (1) JP2657132B2 (de)
CN (1) CN1029738C (de)
AT (1) ATE129715T1 (de)
BG (1) BG60593B1 (de)
CA (1) CA2046956C (de)
CZ (1) CZ280640B6 (de)
DE (1) DE69114198T2 (de)
DK (1) DK0467331T3 (de)
ES (1) ES2081397T3 (de)
GR (1) GR3018330T3 (de)
HR (1) HRP920491B1 (de)
HU (4) HU221803B1 (de)
PL (1) PL166379B1 (de)
RO (1) RO109338B1 (de)
RU (1) RU2045533C1 (de)
SI (1) SI9011409A (de)
SK (1) SK279075B6 (de)
UA (1) UA27105A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
PT1437359E (pt) * 1997-10-16 2007-04-30 Glaxosmithkline Zagreb Novos 3,6-hemicetais da classe dos 9a-azalidos
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
RU2122549C1 (ru) * 1997-12-29 1998-11-27 Закрытое акционерное общество "Фосфосорб" Способ хроматографического выделения и очистки белков, пептидов и их комплексов
HRP970714B1 (en) * 1997-12-31 2003-08-31 Pliva Pharm & Chem Works Beta,beta-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
HRP980646B1 (en) * 1998-12-30 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. Novel oleandomycin derivatives
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
HRP990116B1 (en) * 1999-04-20 2007-10-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. NOVEL 8a AND 9a- 15-MEMBERED LACTAMES
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
CN1193036C (zh) * 2000-03-15 2005-03-16 韩美药品工业株式会社 制备甲红霉素-克拉霉素ⅱ型晶体的方法
DE60114028T2 (de) 2000-08-23 2006-07-13 Wockhardt Ltd. Verfahren zur herstellung von wasserfreiem azithromycin
RU2202619C2 (ru) * 2001-01-09 2003-04-20 Научно-исследовательский институт химии Нижегородского государственного университета им. Н.И. Лобачевского Способ определения общей токсичности твердой, жидкой и газообразной сред
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
EP1483579A4 (de) 2002-02-15 2006-07-12 Merckle Gmbh Konjugate biologisch aktiver verbindungen, verfahren zu ihrer herstellung und verwendung, formulierung und pharmazeutische anwendungen davon
WO2003070254A1 (en) 2002-02-15 2003-08-28 Sympore Gmbh Antibiotic conjugates
WO2003070174A2 (en) 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US7435805B2 (en) * 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
WO2004106353A1 (en) * 2003-05-30 2004-12-09 Pliva - Istrazivacki Institut D.O.O. Process for selective alkylation of macrolide and azalide derivatives
WO2005021567A1 (en) * 2003-09-02 2005-03-10 Pliva - Istrazivacki Institut D.O.O. O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
KR20070105993A (ko) * 2005-01-13 2007-10-31 글락소스미쓰클라인 이스트라지바치키 센타 자그레브 디.오.오. 소염 활성을 갖는 마크로라이드
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
JP2012516305A (ja) 2009-01-30 2012-07-19 グラクソ グループ リミテッド 好中球優位の炎症性疾患の治療のための9−デオキソ−9a−メチル−9a−アザ−9a−ホモエリスロマイシンa誘導体
CN102378763A (zh) 2009-01-30 2012-03-14 葛兰素集团有限公司 消炎的大环内酯
CN101830949B (zh) * 2009-03-13 2012-05-23 上海医药工业研究院 一种阿奇霉素衍生物、其中间体及其制备方法和应用
WO2011131749A1 (en) 2010-04-23 2011-10-27 Glaxo Group Limited New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
CN102952166A (zh) * 2011-08-28 2013-03-06 山东方明药业集团股份有限公司 聚合物支载硼氢阴离子还原剂合成阿奇霉素中间体的方法
WO2013148874A1 (en) * 2012-03-27 2013-10-03 Burnet Michael W Anti-inflammatory macrolides
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds
EP3612543B1 (de) 2017-04-20 2022-11-23 Rising Tide Foundation Ein phosphonium-ion enthaltende azithromycin-derivate als antikrebsmittel
US11427606B2 (en) 2017-04-20 2022-08-30 Rising Tide Foundation Azithromycin derivatives containing a phosphonium ion as anticancer agents
WO2018195446A1 (en) 2017-04-21 2018-10-25 Lisanti Michael P Targeting hypoxic cancer stem cells (cscs) with doxycycline: implications for improving anti-angiogenic therapy
WO2018195434A1 (en) 2017-04-21 2018-10-25 Lisanti Michael P Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs)
US11160821B2 (en) 2017-05-19 2021-11-02 Lunella Biotech, Inc. Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
WO2018213764A1 (en) 2017-05-19 2018-11-22 Lunella Biotech, Inc. Companion diagnostics for mitochondrial inhibitors
CU20190106A7 (es) 2017-06-26 2020-11-30 Lunella Biotech Inc Mitocetoscinas: agentes terapéuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en células cancerosas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシンa誘導体
EP0184921A3 (de) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycinderivate
JPS63107994A (ja) * 1986-05-02 1988-05-12 Taisho Pharmaceut Co Ltd エリスロマイシン誘導体
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents

Also Published As

Publication number Publication date
RU2045533C1 (ru) 1995-10-10
US5250518A (en) 1993-10-05
CA2046956C (en) 1999-01-05
JP2657132B2 (ja) 1997-09-24
ATE129715T1 (de) 1995-11-15
CS219591A3 (en) 1992-03-18
HU9802439D0 (en) 1998-12-28
JPH05132497A (ja) 1993-05-28
SI9011409A (en) 1995-10-31
HU215158B (hu) 1998-12-28
HU221803B1 (hu) 2003-01-28
HU912408D0 (en) 1991-12-30
DE69114198D1 (de) 1995-12-07
BG60593B1 (bg) 1995-09-29
CA2046956A1 (en) 1992-01-19
RO109338B1 (ro) 1995-01-30
HUT59935A (en) 1992-07-28
DK0467331T3 (da) 1996-02-05
EP0467331B1 (de) 1995-11-02
CN1059728A (zh) 1992-03-25
HRP920491A2 (en) 1994-08-31
CN1029738C (zh) 1995-09-13
DE69114198T2 (de) 1996-06-27
PL166379B1 (en) 1995-05-31
HU9202619D0 (en) 1992-12-28
GR3018330T3 (en) 1996-03-31
HU211659A9 (en) 1995-12-28
EP0467331A1 (de) 1992-01-22
BG94837A (bg) 1993-12-24
CZ280640B6 (cs) 1996-03-13
SK279075B6 (sk) 1998-06-03
PL291130A1 (en) 1992-11-16
UA27105A1 (uk) 2000-02-28
ES2081397T3 (es) 1996-03-01
HUT62307A (en) 1993-04-28

Similar Documents

Publication Publication Date Title
GR3018330T3 (en) O-methyl derivatives of azithromycin A, process and intermediates for their preparation, and use thereof in the preparation of pharmaceuticals.
ZA892474B (en) Process for preparing derivatives of baccatine iii and of 10-deacetyl baccatine iii
DK0553202T3 (da) Fremgangsmåde til fremstilling af imidazo(4,5-c)quinolin-4-aminer
DE3270317D1 (en) Derivatives of amino acids and their therapeutic use
CA2146852A1 (en) New substituted pyrazole derivatives, processes for their preparation and their use as herbicides
FI111263B (fi) Uudet erytromysiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä sekä menetelmässä käytettävät välituoteamiinit
MX9805181A (es) Derivados de lactona a partir de derivados de 17.beta- carboxi, carbotio y amida androstano.
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
NO890567D0 (no) Anthracyklin-derivater.
NO961356D0 (no) Antracyklinonderivater, samt anvendelse derav ved amyloidose
CA2148595A1 (en) Molecule labelling using 2-hydrazinopyridine derivatives
ES2145772T3 (es) Uso de un complejo de ibuprofeno-beta-ciclodextrina para administracion oral.
ATE63921T1 (de) 6-amino-anthracycline, verfahren zu ihrer herstellung und ihre verwendung.
DE69025505D1 (de) Tylosin-Derivate
CZ281393B6 (cs) Způsob výroby 6-(substituovaných amino)-propionyl derivátů forskolinu
HUT58065A (en) Process for producing new 4'-epi-4'-aminoanthracyclines and pharmaceutical composiktions comprising same
PT86702A (pt) Process for preparing substituted methanesulphonamidophenethylamines
DK0424248T3 (da) 20,21-dinoreburnamein med substitution i 15-stillingen, fremgangsmåde til deres fremstilling samt mellemprodukter til brug derved, deres anvendelse som lægemidler og præparater med indhold deraf
MY115291A (en) New substituted pyrazole derivatives, processes for their preparation nad their use as herbicides
HUT50127A (en) Process for producing compounds of antiarrythmic activity and pharmaceutical compositions containing
SE8305231D0 (sv) Aminoglycoside derivatives, processes for their production and their use
HUT57718A (en) Process for producing thiourea derivative
MX9802933A (es) Derivados novedosos de amina de 2", 3"-didesoxiglicosidos de epipodofilotoxina, metodo de preparacion de los mismos y uso de los mismos con un farmaco y para tratamientos anticancer.
FI102972B1 (fi) 20-metyyli-5,7-pregneadieeni-3b,21-diolijohdannaisia
MY101624A (en) Novel compounds and prosesses.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O.,

PPPP Transfer of rights

Owner name: PLIVA-ISTRAZIVACKI INSTITUT D.O.O., HR

ODRP Renewal fee for the maintenance of a patent

Payment date: 20070713

Year of fee payment: 18

PBON Lapse due to non-payment of renewal fee

Effective date: 20080719